MOLOGEN Competitors and Similar CompaniesClear all
MOLOGEN's competitors and similar companies include KemPharm and Advaxis.
 MOLOGEN MOLOGEN AG is a biotechnology company specializing in the research and clinical development of innovative drugs in the fields of oncology and infectious diseases. |  KemPharm KemPharm is a biopharmaceutical company focused on the discovery and development of new, safer therapies in the areas of pain, ADHD, and other CNS diseases. | ||
Founding Date | Founding Date 1998 | Founding Date 2006 | Founding Date 2002 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Berlin, DE HQ | Locations Kissimmee, US HQ Blacksburg, US Coralville, US Coralville, US | Locations Princeton, US HQ |
Employees | Employees 4710% decrease | Employees 333% increase | Employees 3540% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 200.5 m | Valuation ($) 2.4 m |
Financial | |||
Revenue (est.) | Revenue (est.) €81k (FY, 2019) | Revenue (est.) $106.5m (FY, 2025) | Revenue (est.) $13k (FY, 2023) |
Cost of goods | Cost of goods €2m (FY, 2019) | Cost of goods N/A | Cost of goods $13k (FY, 2023) |
Net income | Net income (€10.3m) (FY, 2019) | Net income $83.2m (FY, 2025) | Net income ($48.1m) (FY, 2023) |
For sources of this data, please see the company profile
View Company Profiles
KemPharm
HQ
Kissimmee, US
Employees
33↑ 3% increase
KemPharm is a biopharmaceutical company focused on the discovery and development of new, safer therapies in the areas of pain, ADHD, and other CNS diseases.
View company
Advaxis
HQ
Princeton, US
Employees
35↓ 40% decrease
Advaxis is a biotechnology company developing the next generation of cancer immunotherapies.
View company